Cargando…
Rapamycin extends life span of Rb1(+/−) mice by inhibiting neuroendocrine tumors
Chronic treatment of mice with an enterically released formulation of rapamycin (eRapa) extends median and maximum life span, partly by attenuating cancer. The mechanistic basis of this response is not known. To gain a better understanding of these in vivo effects, we used a defined preclinical mode...
Autores principales: | Livi, Carolina B., Hardman, Rulon L., Christy, Barbara A., Dodds, Sherry G., Jones, Diane, Williams, Charnae, Strong, Randy, Bokov, Alex, Javors, Martin A., Ikeno, Yuji, Hubbard, Gene, Hasty, Paul, Sharp, Zelton Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616197/ https://www.ncbi.nlm.nih.gov/pubmed/23454836 |
Ejemplares similares
-
Adaptations to chronic rapamycin in mice
por: Dodds, Sherry G., et al.
Publicado: (2016) -
p53 and rapamycin are additive
por: Christy, Barbara, et al.
Publicado: (2015) -
Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020) -
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
por: Harrison, David E., et al.
Publicado: (2009) -
Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice
por: Rodriguez, Karl A., et al.
Publicado: (2014)